<p>温哥華，不列顛哥倫比亞省 --（Newsfile Corp. -2026 年 5 月 21 日）- Restart Life Sciences Corp.（CSE: HEAL）（FSE: HN30）（OTC Pink: NMLSF）（&#34;Restart Life&#34;或&#34;公司&#34;）很高興地宣佈，已成功完成其之前宣佈的非承銷私人配售（&#34;配售&#34;），向其全資子公司 Holy Crap Foods Inc.（&#34;Holy Crap&#34;）提供單位（&#34;單位&#34;）以建立循環採購訂單（&#34;PO&#34;）融資來源。</p>
<p>公司共發行了 833,334 個單位，每個單位的價格為 0.12 加元，總毛收益為 100,000.08 加元（&#34;配售&#34;）。向關聯方發行單位被視為根據《多邊工具 61-101 - 保護特殊交易中的少數股東權益》（&#34;MI 61-101&#34;）的定義的關聯交易。由於向這些人士發行的單位的公允市場價值不超過公司市值的 25%，公司依賴於 MI 61-101 的正式估值和少數股東批准要求的豁免。</p>
<p>為了直接支持公司的運營增長戰略以及將 Holy Crap 推向美國市場，Restart Life 的首席執行官 Steve Loutskou 認購了配售的 50%（416,666 個單位）。</p>
<p>除了對循環 PO 基金的直接現金注入外，Loutskou 先生和其他公司內部人士通過公開市場的增持繼續展示市場信心。</p>
<p>&#34;我堅決將我的資金投入其中，以確保我們的團隊在進入北美夏季銷售週期時不受阻礙，&#34; Restart Life 的首席執行官 Steve Loutskou 表示。&#34;通過選擇自掏腰包資助</p>
<p>50%</p>
<p>這筆採購訂單的配售，我在強化與股東的對齊。這項融資的結構故意設計得非常精簡，以防止不必要的稀釋，同時作為快速循環的資本工具。隨着 Holy Crap 的訂單量在批發、DTC、亞馬遜和沃爾瑪中持續增長，這些資金將立即解鎖可擴展的生產能力。&#34;</p>
<p>正如公司在 2026 年 5 月 8 日的公告中詳細説明的，配售的毛收益將作為專用的前期營運資金，用於製造和履行待處理的批發和電子商務採購訂單。通過將生產資本隔離到一個循環池中，公司規避了傳統的 60 到 180 天的零售收款滯後時間。一旦分銷商的付款清算，資金將直接返回 PO 池，以立即為後續生產提供融資，保護核心企業財務。</p>
<p>每個在此次交易中發行的單位由一股普通股和一個可轉讓的普通股購買權證（&#34;權證&#34;）組成。每個權證賦予持有人在交易結束後兩（2）年內以每股 0.15 加元的行使價格購買一股額外的普通股。</p>
<p>在此次配售的結束過程中沒有支付中介費。根據適用的加拿大證券法，所有根據配售發行的證券均需遵守法定的四個月零一天的持有期，該持有期將於 2026 年 9 月 21 日到期。</p>
<p>Restart Life Sciences 感謝其股東的持續支持，因為公司在推進其使命並繼續執行其戰略。</p>
<p><strong>關於 Restart Life Sciences Corp.</strong> Restart Life Sciences Corp.是一家總部位於加拿大的生命科學公司，上市於 CSE。有關 Restart Life 的更多信息，請訪問公司網站 www.restartlife.co。</p>
<p><strong>關於 Holy Crap Foods Inc.</strong> Holy Crap 超級種子穀物和 Holy Crap 超級種子燕麥片是提供營養豐富、清潔標籤產品的優質功能性食品品牌，採用簡單、高質量的成分。該品牌總部位於不列顛哥倫比亞省吉布森斯，憑藉強大的消費者信任和重複購買，建立了忠誠且不斷增長的客户基礎。</p>
<p>Holy Crap 的無麩質、非轉基因、高纖維產品定位於快速增長的腸道健康和保健類別，支持消化健康和持續能量，同時作為健康意識消費者的可信賴日常解決方案獲得關注。有關更多信息，請訪問 www.holycrap.com。</p>
<p><strong>代表董事會</strong> Steve Loutskou</p>
<p>首席執行官，Restart Life Sciences Corp. 電話：+1 (778) 819-0244</p>
<p>電子郵件：hello@restartlife.co</p>
<p><strong>前瞻性聲明</strong> 本新聞稿包含構成&#34;前瞻性聲明&#34;的陳述。這些前瞻性聲明涉及已知和未知的風險、不確定性及其他因素，可能導致 Restart Life Sciences 的實際結果、表現或成就，或行業的發展與預期的結果、表現或成就存在重大差異。前瞻性聲明是指不是歷史事實的陳述，通常但不總是通過&#34;預計&#34;、&#34;計劃&#34;、&#34;預期&#34;、&#34;相信&#34;、&#34;打算&#34;、&#34;估計&#34;、&#34;項目&#34;、&#34;潛在&#34;及類似表達來識別，或事件或條件&#34;將&#34;、&#34;會&#34;、&#34;可能&#34;、&#34;可以&#34;或&#34;應該&#34;發生。</p>
<p>加拿大證券交易所及其市場監管機構（根據加拿大證券交易所政策中的定義）對本公告的充分性或準確性不承擔任何責任。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/298268_0ccd8c0e34e30a50_logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/298268_0ccd8c0e34e30a50_logo.jpg"/></p>
<p>要查看本新聞稿的源版本，請訪問 https://www.newsfilecorp.com/release/298268</p>
<p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/298268/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/298268/375"/></p>

<p>Restart Life Sciences Corp. 已完成一項非承銷私人配售，發行了 833,334 個單位，每個單位價格為 0.12 加元，籌集了 100,000 加元。首席執行官 Steve Loutskou 認購了該配售的 50%，進一步表明他對公司增長戰略的承諾。這筆資金將用於其子公司 Holy Crap Foods Inc. 的生產和訂單履行，同時儘量減少稀釋。每個單位包括一股普通股和一個未來購買的認股權證。所有證券均需遵守四個月的持有期</p>

<p>Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) (&#34;Restart Life&#34; or the &#34;Company&#34;) is pleased to announce that it has successfully closed its previously announced non-brokered private placement offering (the &#34;Offering&#34;) of units (the &#34;Units&#34;) to establish a revolving purchase order (&#34;PO&#34;) financing source for its wholly owned subsidiary, Holy Crap Foods Inc. (&#34;Holy Crap&#34;).</p>
<div class="lb-trans"><p>温哥華，不列顛哥倫比亞省 --（Newsfile Corp. -2026 年 5 月 21 日）- Restart Life Sciences Corp.（CSE: HEAL）（FSE: HN30）（OTC Pink: NMLSF）（&#34;Restart Life&#34;或&#34;公司&#34;）很高興地宣佈，已成功完成其之前宣佈的非承銷私人配售（&#34;配售&#34;），向其全資子公司 Holy Crap Foods Inc.（&#34;Holy Crap&#34;）提供單位（&#34;單位&#34;）以建立循環採購訂單（&#34;PO&#34;）融資來源。</p>
</div><p>The Company has issued a total of 833,334 Units at a price of CAD $0.12 per Unit for aggregate gross proceeds of CAD $100,000.08 (the &#34;Offering&#34;). The issuance of Units to related parties is considered to be a related party transaction within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (&#34;MI 61-101&#34;). The Company has relied on the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 as the fair market value of the Units issued to such persons does not exceed 25% of the Company's market capitalization.</p>
<div class="lb-trans"><p>公司共發行了 833,334 個單位，每個單位的價格為 0.12 加元，總毛收益為 100,000.08 加元（&#34;配售&#34;）。向關聯方發行單位被視為根據《多邊工具 61-101 - 保護特殊交易中的少數股東權益》（&#34;MI 61-101&#34;）的定義的關聯交易。由於向這些人士發行的單位的公允市場價值不超過公司市值的 25%，公司依賴於 MI 61-101 的正式估值和少數股東批准要求的豁免。</p>
</div><p>Demonstrating direct commitment to the Company's operational growth strategy and the launch of Holy Crap into the United States market, Steve Loutskou, Chief Executive Officer of Restart Life, subscribed for 50% of the Offering (416,666 Units).</p>
<div class="lb-trans"><p>為了直接支持公司的運營增長戰略以及將 Holy Crap 推向美國市場，Restart Life 的首席執行官 Steve Loutskou 認購了配售的 50%（416,666 個單位）。</p>
</div><p>In addition to this direct cash injection into the revolving PO fund, Mr. Loutskou and other corporate insiders have continued to demonstrate market confidence through open-market accumulations.</p>
<div class="lb-trans"><p>除了對循環 PO 基金的直接現金注入外，Loutskou 先生和其他公司內部人士通過公開市場的增持繼續展示市場信心。</p>
</div><p>&#34;I am firmly putting my money where my mouth is to ensure our teams are unencumbered as we head into a North American summer sales cycle,&#34; said Steve Loutskou, CEO of Restart Life. &#34;By choosing to fund</p>
<div class="lb-trans"><p>&#34;我堅決將我的資金投入其中，以確保我們的團隊在進入北美夏季銷售週期時不受阻礙，&#34; Restart Life 的首席執行官 Steve Loutskou 表示。&#34;通過選擇自掏腰包資助</p>
</div><p>50%</p>
<div class="lb-trans"><p>50%</p>
</div><p>of this purchase order placement out of my own pocket, I am reinforcing my alignment with our shareholders. This financing was intentionally structured to be exceptionally lean to prevent unnecessary dilution while serving as a rapid-recycling capital tool. As Holy Crap's order volume continues to grow with Wholesale, DTC, Amazon and Walmart, these funds will immediately unlock scalable production runs.&#34;</p>
<div class="lb-trans"><p>這筆採購訂單的配售，我在強化與股東的對齊。這項融資的結構故意設計得非常精簡，以防止不必要的稀釋，同時作為快速循環的資本工具。隨着 Holy Crap 的訂單量在批發、DTC、亞馬遜和沃爾瑪中持續增長，這些資金將立即解鎖可擴展的生產能力。&#34;</p>
</div><p>As detailed in the Company's announcement on May 8, 2026, the gross proceeds from the Offering will serve as dedicated upfront working capital to manufacture and fulfill pending wholesale and e-commerce purchase orders. By isolating production capital into a recycling pool, the Company circumvents traditional 60-to-180-day retail collection lag times. Once payments are cleared from distributors, funds return directly to the PO pool to instantly finance successive production runs, safeguarding the core corporate treasury.</p>
<div class="lb-trans"><p>正如公司在 2026 年 5 月 8 日的公告中詳細説明的，配售的毛收益將作為專用的前期營運資金，用於製造和履行待處理的批發和電子商務採購訂單。通過將生產資本隔離到一個循環池中，公司規避了傳統的 60 到 180 天的零售收款滯後時間。一旦分銷商的付款清算，資金將直接返回 PO 池，以立即為後續生產提供融資，保護核心企業財務。</p>
</div><p>Each Unit issued under the closing consists of one common share and one transferable common share purchase warrant (a &#34;Warrant&#34;). Each Warrant entitles the holder to purchase one additional common share for a period of two (2) years from the date of closing at an exercise price of CAD $0.15 per common share.</p>
<div class="lb-trans"><p>每個在此次交易中發行的單位由一股普通股和一個可轉讓的普通股購買權證（&#34;權證&#34;）組成。每個權證賦予持有人在交易結束後兩（2）年內以每股 0.15 加元的行使價格購買一股額外的普通股。</p>
</div><p>No finder's fees were paid in connection with the closing of this Offering. All securities issued pursuant to the Offering are subject to a statutory four-month and one-day hold period expiring September 21, 2026, under applicable Canadian securities laws.</p>
<div class="lb-trans"><p>在此次配售的結束過程中沒有支付中介費。根據適用的加拿大證券法，所有根據配售發行的證券均需遵守法定的四個月零一天的持有期，該持有期將於 2026 年 9 月 21 日到期。</p>
</div><p>Restart Life Sciences would like to thank its shareholders for their ongoing support as the Company advances its mission and continues to execute on its strategy.</p>
<div class="lb-trans"><p>Restart Life Sciences 感謝其股東的持續支持，因為公司在推進其使命並繼續執行其戰略。</p>
</div><p><strong>About Restart Life Sciences Corp.</strong> Restart Life Sciences Corp. is a Canadian-based life sciences company listed on the CSE. For more information about Restart Life, please visit the Company's website at www.restartlife.co.</p>
<div class="lb-trans"><p><strong>關於 Restart Life Sciences Corp.</strong> Restart Life Sciences Corp.是一家總部位於加拿大的生命科學公司，上市於 CSE。有關 Restart Life 的更多信息，請訪問公司網站 www.restartlife.co。</p>
</div><p><strong>About Holy Crap Foods Inc.</strong> Holy Crap Superseed Cereal and Holy Crap Superseed Oatmeal are premium functional food brands offering nutrient-dense, clean-label products made with simple, high-quality ingredients. Based in Gibsons, British Columbia, the brand has built a loyal and growing customer base across Canada, driven by strong consumer trust and repeat purchases.</p>
<div class="lb-trans"><p><strong>關於 Holy Crap Foods Inc.</strong> Holy Crap 超級種子穀物和 Holy Crap 超級種子燕麥片是提供營養豐富、清潔標籤產品的優質功能性食品品牌，採用簡單、高質量的成分。該品牌總部位於不列顛哥倫比亞省吉布森斯，憑藉強大的消費者信任和重複購買，建立了忠誠且不斷增長的客户基礎。</p>
</div><p>Positioned within the fast-growing gut health and wellness category, Holy Crap's gluten-free, non-GMO, high-ﬁber products support digestive health and sustained energy, while gaining traction as a trusted, everyday solution for health-conscious consumers. For more information, visit www.holycrap.com</p>
<div class="lb-trans"><p>Holy Crap 的無麩質、非轉基因、高纖維產品定位於快速增長的腸道健康和保健類別，支持消化健康和持續能量，同時作為健康意識消費者的可信賴日常解決方案獲得關注。有關更多信息，請訪問 www.holycrap.com。</p>
</div><p><strong>On behalf of the Board of Directors</strong> Steve Loutskou</p>
<div class="lb-trans"><p><strong>代表董事會</strong> Steve Loutskou</p>
</div><p>Chief Executive Ofﬁcer, Restart Life Sciences Corp. Tel: +1 (778) 819-0244</p>
<div class="lb-trans"><p>首席執行官，Restart Life Sciences Corp. 電話：+1 (778) 819-0244</p>
</div><p>Email: hello@restartlife.co</p>
<div class="lb-trans"><p>電子郵件：hello@restartlife.co</p>
</div><p><strong>Forward-Looking Statements</strong> This news release contains statements that constitute &#34;forward-looking statements.&#34; Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Restart Life Sciences' actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identiﬁed by the words &#34;expects,&#34; &#34;plans,&#34; &#34;anticipates,&#34; &#34;believes,&#34; &#34;intends,&#34; &#34;estimates,&#34; &#34;projects,&#34; &#34;potential&#34; and similar expressions, or that events or conditions &#34;will,&#34; &#34;would,&#34; &#34;may,&#34; &#34;could&#34; or &#34;should&#34; occur.</p>
<div class="lb-trans"><p><strong>前瞻性聲明</strong> 本新聞稿包含構成&#34;前瞻性聲明&#34;的陳述。這些前瞻性聲明涉及已知和未知的風險、不確定性及其他因素，可能導致 Restart Life Sciences 的實際結果、表現或成就，或行業的發展與預期的結果、表現或成就存在重大差異。前瞻性聲明是指不是歷史事實的陳述，通常但不總是通過&#34;預計&#34;、&#34;計劃&#34;、&#34;預期&#34;、&#34;相信&#34;、&#34;打算&#34;、&#34;估計&#34;、&#34;項目&#34;、&#34;潛在&#34;及類似表達來識別，或事件或條件&#34;將&#34;、&#34;會&#34;、&#34;可能&#34;、&#34;可以&#34;或&#34;應該&#34;發生。</p>
</div><p>Neither the Canadian Securities Exchange nor its Market Regulator (as that term is deﬁned in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.</p>
<div class="lb-trans"><p>加拿大證券交易所及其市場監管機構（根據加拿大證券交易所政策中的定義）對本公告的充分性或準確性不承擔任何責任。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.newsfilecorp.com/files/8801/298268_0ccd8c0e34e30a50_logo.jpg" alt="" original-src="https://images.newsfilecorp.com/files/8801/298268_0ccd8c0e34e30a50_logo.jpg"/></p>
<p>To view the source version of this press release, please visit https://www.newsfilecorp.com/release/298268</p>
<div class="lb-trans"><p>要查看本新聞稿的源版本，請訪問 https://www.newsfilecorp.com/release/298268</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/298268/375" alt="" original-src="https://api.newsfilecorp.com/newsinfo/298268/375"/></p>

Restart Life Sciences 完成專用訂單融資私募；首席執行官認購了 50% 的發行份額 | NMLSF 股票新聞